Organogenesis Holdings Inc - Ordinary Shares - Class A
ORGO
Get informed when a big investor buys or sells
+ FollowMarket Cap$313.97M
Close$
$0.24
90.2% downside
Current Fair Value
90.2% downsideOvervalued by 90.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $313.97 Million |
|---|---|
| Enterprise Value | $293.45 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.16 |
| Beta | 1.33 |
| Outstanding Shares | 127,797,013 |
Return
| Return on Equity | 5.13% |
|---|---|
| Return on Assets | 2.41% |
| Return on Invested Capital | 0.48% |
Valuation & Multiples
| P/E Ratio | -1097.97 |
|---|---|
| PEG | -685.79 |
| Price to Sales | 0.61 |
| Price to Book Ratio | 1.22 |
| Enterprise Value to Revenue | 0.57 |
| Enterprise Value to EBIT | 139.14 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$43.26 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$54.27 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 88.43% |
|---|---|
| Total Calls | 36,900▲ 204.96% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.99%▼ 5.78% |
|---|---|
| Total Invested | $147.61M▼ 58.97% |
| Investors Holding | 121▼ 27.00% |
ESG Score
No data